Biogen Inc. buy Jefferies Financial Group Inc.
Start price
28.11.25
/
50%
€156.30
Target price
28.11.26
€181.27
Performance (%)
12.63%
Price
31.07.26
€176.04
Summary
This prediction is currently active. The prediction currently has a performance of 12.63%. This prediction currently runs until 28.11.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.990% | -0.990% |
| iShares Core DAX® | 2.591% | 2.691% |
| iShares Nasdaq 100 | -0.915% | -7.368% |
| iShares Nikkei 225® | 0.145% | -10.196% |
| iShares S&P 500 | -0.367% | -0.833% |
Comments by Jefferies_Financial_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Jefferies Financial Group Inc. from $190.00 to $210.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat